Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Addex Therapeutics (ADXN) Equity Income (2024 - 2025)

Historic Equity Income for Addex Therapeutics (ADXN) over the last 2 years, with Q3 2025 value amounting to -$1.1 million.

  • Addex Therapeutics' Equity Income fell 896.27% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $942.6 billion, marking a year-over-year change of. This contributed to the annual value of -$2.5 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Addex Therapeutics' Equity Income stood at -$1.1 million, which was down 896.27% from -$1.5 million recorded in Q2 2025.
  • Over the past 5 years, Addex Therapeutics' Equity Income peaked at $942.6 billion during Q1 2025, and registered a low of -$2.5 million during Q4 2024.